Table 5 Proportion of patients experiencing radiographic progression (Δ SHS ≥ 3) within each time interval against categories of diseases activity (time-integrated standardized CRP scores) in the same period
Time-integrated inflammation | 0–6-month progression | 6-months–1-year progression | 1-year–2-year progression | 2-year–3-year progression | ||||
|---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | No | Yes | |
No (CRP ≤ 5) | 65 (77.4%) | 19 (22.6%) | 87 (82.9%) | 18 (17.1%) | 71 (80.7%) | 17 (19.3%) | 81 (88.0%) | 11 (12.0%) |
Mild (CRP > 5 to ≤ 10) | 49 (77.8%) | 14 (22.2%) | 34 (87.2%) | 5 (12.8%) | 31 (79.5%) | 8 (20.5%) | 22 (73.3%) | 8 (26.7%) |
Moderate (CRP > 10 to ≤ 30) | 23 (67.6%) | 11 (32.4%) | 12 (75.0%) | 4 (25.0%) | 13 (61.9%) | 8 (38.1%) | 17 (73.9%) | 6 (26.1%) |
High (CRP > 30) | 7 (63.6%) | 4 (36.4%) | 4 (80.0%) | 1 (20.0%) | 0 (0.0%) | 2 (100%) | 1 (50%) | 1 (50.0%) |
Total | 144 (75.0%) | 48 (25.0%) | 135 (82.8%) | 28 (17.2%) | 115 (76.7%) | 35 (23.3%) | 121 (82.3%) | 26 (17.7%) |